logo

For the Inventor, By the Inventor

Utrecht, Netherlands

Genmab B.v.


USPTO Granted Patents = 10


Trademarks = 2

Forward Citations = 29

Loading Chart...
Loading Chart...

20 inventors (with patents filed for the assignee):

goldMedal Janine Schuurman (8 out of 58 patents)

silverMedal Frank Beurskens (6 out of 15 patents)

bronzeMedal Paul Parren (6 out of 136 patents)

4.  Rob N De Jong (5 out of 17 patents)

5.  Kristin Strumane (5 out of 5 patents)

6.  Aran Frank Labrijn (4 out of 37 patents)

7.  Marije Overdijk (3 out of 10 patents)

8.  Simone Oostindie (2 out of 9 patents)

9.  Esther Breij (2 out of 14 patents)

10.  Claudine Brigitte Fernande Vermot-Desroches (2 out of 2 patents)

11.  Olivier Frédéric Subiger (2 out of 2 patents)

12.  Laurence Françoise Jeanne-Marie Bourdin (2 out of 2 patents)

13.  Rik Rademaker (1 out of 32 patents)

14.  Arjen Vlug (1 out of 1 patent)

15.  Sandra Verploegen (1 out of 10 patents)


10 patents:

1. 12649798 - POLYPEPTIDE VARIANTS AND USES THEREOF (2026-06-09),
2. 12338289 - Antibody variant combinations and uses thereof (2025-06-24),
3. 12247080 - Anti-DR5 antibodies and methods of use thereof (2025-03-11),
4. 12173076 - Polypeptide variants and uses thereof (2024-12-24),
5. 12049512 - Antibody variants and uses thereof (2024-07-30),
6. 11180572 - Dimeric protein with triple mutations (2021-11-23),
7. 10882913 - Anti-DR5 antibodies and methods of use thereof (2021-01-05),
8. 10759867 - Antibody variants and uses thereof (2020-09-01),
9. 10647774 - Anti-DR5 family antibodies, bispecific or multivalent anti-DR5 family antibodies and methods of use thereof (2020-05-12),
10. 9611327 - Anti-DR5 family antibodies, bispecific or multivalent anti-DR5 family antibodies and methods of use thereof (2017-04-04),
Company Overview
Genmab B.V. is a biotechnology company based in Utrecht, Netherlands, specializing in the development of differentiated antibody therapeutics for the treatment of cancer. The company focuses on innovative research and technology in the field of immuno-oncology, leveraging its proprietary antibody platforms to create novel therapies. Genmab collaborates with various pharmaceutical partners to advance its pipeline, aiming to improve patient outcomes through targeted and effective treatment options.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

10 Patents

#14 in Utrecht

#619 in Netherlands

#56,047 in the World

Utrecht, NL
Utrecht, Netherlands

Genmab B.v.

Forward Citations = 29

20 inventors:

goldMedal Janine Schuurman (8 out of 58 patents)

silverMedal Frank Beurskens (6 out of 15 patents)

bronzeMedal Paul Parren (6 out of 136 patents)

4.  Rob N De Jong (5 out of 17 patents)

5.  Kristin Strumane (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Genmab B.v.. Retrieved from https://idiyas.com/company/genmab-b-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…